Cargando…

Radiofrequency ablation for the treatment of haemorrhoidal disease: a minimally invasive and effective treatment modality

BACKGROUND: Haemorrhoidal disease (HD) is a common colorectal condition that often requires surgical treatment. Less invasive procedures are usually more acceptable to patients. The aim of this study was to report the outcome of a novel and minimally invasive technique employing a radiofrequency abl...

Descripción completa

Detalles Bibliográficos
Autores principales: Eddama, M. M. R., Everson, M., Renshaw, S., Taj, T., Boulton, R., Crosbie, J., Cohen, C. Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736898/
https://www.ncbi.nlm.nih.gov/pubmed/31399891
http://dx.doi.org/10.1007/s10151-019-02054-2
_version_ 1783450572033097728
author Eddama, M. M. R.
Everson, M.
Renshaw, S.
Taj, T.
Boulton, R.
Crosbie, J.
Cohen, C. Richard
author_facet Eddama, M. M. R.
Everson, M.
Renshaw, S.
Taj, T.
Boulton, R.
Crosbie, J.
Cohen, C. Richard
author_sort Eddama, M. M. R.
collection PubMed
description BACKGROUND: Haemorrhoidal disease (HD) is a common colorectal condition that often requires surgical treatment. Less invasive procedures are usually more acceptable to patients. The aim of this study was to report the outcome of a novel and minimally invasive technique employing a radiofrequency ablation (RFA) energy (Rafaelo(®)) to treat HD. METHODS: A total number of 27 patients who had RFA for the treatment of HD were recruited to this study. The procedure was performed under deep sedation and local anaesthesia. Patients’ demographics; haemorrhoid severity score (HSS); quality of life; pain and satisfaction scores; and recurrence rate were recorded. RESULTS: The mean age of the patients was 46 (SD 14) years, 18 (67%) males and 9 (33%) females. The mean body mass index was 25 (SD 4) kg/m(2). The predominant symptom of all patients was per-rectal bleeding. HSS improved from 7.2 (SD 1.9) before the procedure to 1.6 (SD 1) after the procedure (p < 0.0001). Postoperative pain scores on a scale of 0–10 were 0, 2 (SD 2), 1 (SD 2), and 0 on immediate, day-1, day-3, and 2-month follow-up questionnaire. The mean satisfacion score was 9 (SD 1.5) out of 10 on 2-month follow-up. Mean time until patients returned to normal daily activity was 3 (SD 1) days following the procedure. Quality-of-life assessments including: visual analogue scale scores (before: mean 70, SD 23; after: mean 82, SD 16; p < 0.001) and EQ-5D-5L (before: mean 0.84, SD 0.15; after: mean 0.94, SD 0.13; p < 0.05) were significantly improved. The mean length of follow-up for recurrence of symptoms was 20 months (range 12–32 months). One patient (4%) reported the recurrence of rectal bleeding 12 months after the procedure. CONCLUSIONS: RFA for the treatment of HD is safe and effective in achieving symptomatic relief. It is associated with minimal postoperative pain and low incidence of recurrence.
format Online
Article
Text
id pubmed-6736898
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-67368982019-09-23 Radiofrequency ablation for the treatment of haemorrhoidal disease: a minimally invasive and effective treatment modality Eddama, M. M. R. Everson, M. Renshaw, S. Taj, T. Boulton, R. Crosbie, J. Cohen, C. Richard Tech Coloproctol Technical Note BACKGROUND: Haemorrhoidal disease (HD) is a common colorectal condition that often requires surgical treatment. Less invasive procedures are usually more acceptable to patients. The aim of this study was to report the outcome of a novel and minimally invasive technique employing a radiofrequency ablation (RFA) energy (Rafaelo(®)) to treat HD. METHODS: A total number of 27 patients who had RFA for the treatment of HD were recruited to this study. The procedure was performed under deep sedation and local anaesthesia. Patients’ demographics; haemorrhoid severity score (HSS); quality of life; pain and satisfaction scores; and recurrence rate were recorded. RESULTS: The mean age of the patients was 46 (SD 14) years, 18 (67%) males and 9 (33%) females. The mean body mass index was 25 (SD 4) kg/m(2). The predominant symptom of all patients was per-rectal bleeding. HSS improved from 7.2 (SD 1.9) before the procedure to 1.6 (SD 1) after the procedure (p < 0.0001). Postoperative pain scores on a scale of 0–10 were 0, 2 (SD 2), 1 (SD 2), and 0 on immediate, day-1, day-3, and 2-month follow-up questionnaire. The mean satisfacion score was 9 (SD 1.5) out of 10 on 2-month follow-up. Mean time until patients returned to normal daily activity was 3 (SD 1) days following the procedure. Quality-of-life assessments including: visual analogue scale scores (before: mean 70, SD 23; after: mean 82, SD 16; p < 0.001) and EQ-5D-5L (before: mean 0.84, SD 0.15; after: mean 0.94, SD 0.13; p < 0.05) were significantly improved. The mean length of follow-up for recurrence of symptoms was 20 months (range 12–32 months). One patient (4%) reported the recurrence of rectal bleeding 12 months after the procedure. CONCLUSIONS: RFA for the treatment of HD is safe and effective in achieving symptomatic relief. It is associated with minimal postoperative pain and low incidence of recurrence. Springer International Publishing 2019-08-09 2019 /pmc/articles/PMC6736898/ /pubmed/31399891 http://dx.doi.org/10.1007/s10151-019-02054-2 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Technical Note
Eddama, M. M. R.
Everson, M.
Renshaw, S.
Taj, T.
Boulton, R.
Crosbie, J.
Cohen, C. Richard
Radiofrequency ablation for the treatment of haemorrhoidal disease: a minimally invasive and effective treatment modality
title Radiofrequency ablation for the treatment of haemorrhoidal disease: a minimally invasive and effective treatment modality
title_full Radiofrequency ablation for the treatment of haemorrhoidal disease: a minimally invasive and effective treatment modality
title_fullStr Radiofrequency ablation for the treatment of haemorrhoidal disease: a minimally invasive and effective treatment modality
title_full_unstemmed Radiofrequency ablation for the treatment of haemorrhoidal disease: a minimally invasive and effective treatment modality
title_short Radiofrequency ablation for the treatment of haemorrhoidal disease: a minimally invasive and effective treatment modality
title_sort radiofrequency ablation for the treatment of haemorrhoidal disease: a minimally invasive and effective treatment modality
topic Technical Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736898/
https://www.ncbi.nlm.nih.gov/pubmed/31399891
http://dx.doi.org/10.1007/s10151-019-02054-2
work_keys_str_mv AT eddamammr radiofrequencyablationforthetreatmentofhaemorrhoidaldiseaseaminimallyinvasiveandeffectivetreatmentmodality
AT eversonm radiofrequencyablationforthetreatmentofhaemorrhoidaldiseaseaminimallyinvasiveandeffectivetreatmentmodality
AT renshaws radiofrequencyablationforthetreatmentofhaemorrhoidaldiseaseaminimallyinvasiveandeffectivetreatmentmodality
AT tajt radiofrequencyablationforthetreatmentofhaemorrhoidaldiseaseaminimallyinvasiveandeffectivetreatmentmodality
AT boultonr radiofrequencyablationforthetreatmentofhaemorrhoidaldiseaseaminimallyinvasiveandeffectivetreatmentmodality
AT crosbiej radiofrequencyablationforthetreatmentofhaemorrhoidaldiseaseaminimallyinvasiveandeffectivetreatmentmodality
AT cohencrichard radiofrequencyablationforthetreatmentofhaemorrhoidaldiseaseaminimallyinvasiveandeffectivetreatmentmodality